ArticleFrontiers in neurology
Comparison of PNI, HALP, and modified HALP scores in predicting 90-day mortality in elderly patients with acute ischemic stroke.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lactate-to-albumin ratio, C-reactive protein-to-albumin ratio, and prognostic nutritional index in acute and critical care: A focused mini-review.World journal of critical care medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute ischemic stroke (AIS) remains a major cause of mortality and disability, with older adults disproportionately affected. We aimed to evaluate and compare the prognostic utility of the Prognostic Nutritional Index (PNI), the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score, and the modified HALP (mHALP) index for predicting 90-day mortality after AIS in a cohort predominantly composed of elderly patients. Methods: We conducted a single-center retrospective cohort study including 151 adult patients with radiologically confirmed AIS admitted to the emergency department between January 2021 and December 2024. Demographics, comorbidities, and laboratory parameters obtained within 24 hours of admission were recorded, and baseline stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS). PNI, HALP, and mHALP were calculated from routine blood tests. The primary outcome was all-cause 90-day mortality. Associations with mortality were examined using univariate and pre-specified multivariable logistic regression models adjusted for age and NIHSS. Discriminatory performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: Overall, 26 patients (17.2%) died within 90 days. Non-survivors were older and had significantly lower albumin, hemoglobin, lymphocyte counts, PNI, and HALP values than survivors, and higher NIHSS at presentation. In univariate analyses, PNI, HALP, and mHALP were significantly associated with 90-day mortality. In multivariable models adjusted for age and NIHSS, both PNI and HALP remained independently associated with 90-day mortality, whereas the association for mHALP was attenuated and did not reach conventional statistical significance. ROC analyses indicated fair discrimination for PNI and HALP, modest-to-fair performance for mHALP, and NIHSS performance comparable to a clinical reference. Discussion: In this AIS cohort, simple immunonutritional indices-particularly PNI and HALP-were independently associated with 90-day mortality and demonstrated fair discriminative ability, supporting their potential role as adjunctive tools for early risk stratification. These findings warrant validation in larger prospective multicenter cohorts and further clarification of the prognostic contribution of mHALP in AIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.